Immediate Impact
7 from Science/Nature 79 standout
Citing Papers
Pancreatic cancer: Advances and challenges
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Works of Stephen J Chanock being referenced
ABO Blood Group and the Risk of Pancreatic Cancer
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Stephen J Chanock | 98 | 96 | 156 | 151 | 119 | 7 | 425 | |
| E Liu | 75 | 33 | 224 | 231 | 112 | 8 | 509 | |
| Robert H. Gersh | 44 | 30 | 150 | 187 | 202 | 8 | 495 | |
| K. W. Jauch | 124 | 171 | 214 | 79 | 106 | 9 | 508 | |
| Gretchen Taylor | 117 | 52 | 314 | 144 | 42 | 10 | 493 | |
| Paul E. Desrochers | 232 | 40 | 115 | 135 | 105 | 8 | 495 | |
| Brigitte Puig | 205 | 70 | 220 | 165 | 107 | 11 | 511 | |
| GF Nash | 106 | 61 | 176 | 132 | 104 | 8 | 466 | |
| Alexis Norris-Kirby | 147 | 36 | 161 | 176 | 45 | 7 | 477 | |
| LC Bowman | 57 | 20 | 153 | 128 | 155 | 7 | 423 | |
| Kathryn Sibley | 52 | 127 | 89 | 306 | 48 | 7 | 418 |
All Works
Loading papers...